Patent Assignment
Reel/Frame 075769/0102
Patent Security Agreement
Recorded: 2026-06-03
Pages: 12
Assignor
MINERALYS THERAPEUTICS, INC.
Executed: 2026-06-02
Assignee
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties
(24)
CYP11B2 Beta Hydroxylase Inhibitors for Hypertension
Application:
63/105,745 →
CYP11B2 Beta Hydroxylase Inhibitors for Hypertension
Application:
63/223,719 →
CYP11B2 Beta Hydroxylase Inhibitors for Hypertension
Application:
18/250,402 →
Publication:
US US20240009201A1
Methods of Treating Hypertension in Obese Subjects
Application:
63/400,305 →
Methods of Treating Hypertension in Obese Subjects
Application:
19/104,834 →
Publication:
US US20260053811A1
Methods of Treating Hypertension with a Combination of an Aldosterone Synthase Inhibitor and a Diuretic
Application:
63/400,312 →
Methods of Treating Hypertension with a Combination of an Aldosterone Synthase Inhibitor and a Diuretic
Application:
63/425,803 →
Methods of Treating Hypertension with a Combination of an Aldosterone Synthase Inhibitor and a Diuretic
Application:
19/104,845 →
Publication:
US US20260053812A1
Methods of Treating Chronic Kidney Disease or Ckd and Hypertension with Lorundrostat, or a Combination of Lorundrostat and a SGLT2 Inhibitor
Application:
63/596,658 →
Methods of Treating Chronic Kidney Disease (Ckd) or Ckd and Hypertension with Lorundrostat, or a Combination of Lorundrostat and a SGLT2 Inhibitor
Application:
19/503,181 →
Methods of Treating Hypertension with a Combination of Lorundrostat and Two or More Anti-Hypertensive Medications
Application:
63/605,957 →
Methods of Treating Hypertension with a Combination of Lorundrostat and Two or More Anti-Hypertensive Medications
Application:
63/515,917 →
Methods of Treating Hypertension with a Combination of Lorundrostat and Two or More Anti-Hypertensive Medications
Application:
19/502,540 →
Methods of Treating Obstructive Sleep Apnea (Osa), or Osa and Hypertension with an Aldosterone Synthase Inhibitor
Application:
63/742,609 →
Methods of Treating Heart Failure with Preserved Ejection Fraction (Hfpef)
Application:
63/743,545 →
Methods of Treating Left Ventricular Diastolic Dysfunction (Lvdd) and Heart Failure with Preserved Ejection Fraction (Hfpef)
Application:
63/841,639 →
Methods of Treating Left Ventricular Diastolic Dysfunction (Lvdd) and Heart Failure with Preserved Ejection Fraction (Hfpef)
Application:
63/913,584 →
Soluble Pharmaceutical Compositions Comprising Salts of Disubstituted 1, 2, 4-Triazine Compound
Application:
63/223,711 →
Soluble Pharmaceutical Compositions Comprising Salts of Disubstituted 1, 2, 4-Triazine Compound
Application:
18/580,999 →
Publication:
US US20240366616A1
Methods of Treating Hypertension by Periodic Suppression of Aldosterone Synthase
Application:
63/300,967 →
Methods of Treating Hypertension by Periodic Suppression of Aldosterone Synthase
Application:
63/400,301 →
Methods of Treating Hypertension by Periodic Suppression of Aldosterone Synthase
Application:
18/730,540 →
Publication:
US US20250099475A1
Process for Producing Triazine Compound
Application:
63/669,645 →
Process for Producing Triazine Compound
Application:
19/519,590 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 25, 2021
From: SLINGSBY, BRIAN TAYLOR; WATT, WILLIAM CONNOLLY
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 057892/0919 →
Assignment of Assignor's Interest
Oct 25, 2021
From: SLINGSBY, BRIAN TAYLOR; WATT, WILLIAM CONNOLLY; RODMAN, DAVID
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 057903/0822 →
Assignment of Assignor's Interest
May 4, 2022
From: MCKEAN, ROBERT
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 059813/0073 →
Assignment of Assignor's Interest
May 4, 2022
From: OHASHI, YOSHINORI; OZAKI, FUMINORI; OHSHIMA, HIROKI; NAGATA, HIROOMI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 059813/0060 →
Assignment of Assignor's Interest
Jan 19, 2023
From: SHIMIZU, HIDETOSHI; OTA, YOSHIYASU; ORIHASHI, MADORI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 062425/0650 →
Assignment of Assignor's Interest
Jan 23, 2023
From: SHI, HIDETOSHI; OTA, YOSHIYASU; ORI, MADORI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 062452/0282 →
Assignment of Assignor's Interest
Jan 31, 2023
From: RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 062548/0774 →
Assignment of Assignor's Interest
Feb 2, 2023
From: RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS, INC
Reel/Frame 062568/0260 →
Assignment of Assignor's Interest
Feb 2, 2023
From: RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS, INC
Reel/Frame 062568/0174 →
Assignment of Assignor's Interest
Apr 26, 2023
From: SLINGSBY, BRIAN TAYLOR; WATT, WILLIAM CONNOLLY; RODMAN, DAVID
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 063452/0242 →
Assignment of Assignor's Interest
Jan 22, 2024
From: MCKEAN, ROBERT; THIBERT, ROCH; VADAS, ELIZABETH
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 066196/0046 →
Assignment of Assignor's Interest
Jan 24, 2024
From: OHASHI, YOSHINORI; OZAKI, FUMINORI; OHSHIMA, HIROKI; NAGATA, HIROOMI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 066233/0666 →
Assignment of Assignor's Interest
Jul 3, 2024
From: RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 067906/0564 →
Assignment of Assignor's Interest
Jul 16, 2024
From: RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 067996/0136 →
Assignment of Assignor's Interest
Jul 16, 2024
From: RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 067996/0318 →
Assignment of Assignor's Interest
Jul 22, 2024
From: SHIMIZU, HIDETOSHI; OTA, YOSHIYASU; ORIHASHI, MADORI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 068041/0430 →
Assignment of Assignor's Interest
Jul 22, 2024
From: SLINGSBY, BRIAN TAYLOR; RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS INC.
Reel/Frame 068041/0425 →
Assignment of Assignor's Interest
Aug 28, 2024
From: YOSHIDA, KAZUKI; SAKAGUCHI, RYO
To: KAWAKEN FINE CHEMICALS CO., LTD.
Reel/Frame 068422/0752 →
Assignment of Assignor's Interest
Aug 28, 2024
From: KAWAKEN FINE CHEMICALS CO., LTD.
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 068422/0680 →
Assignment of Assignor's Interest
Aug 28, 2024
From: MCKEAN, ROBERT; CHRISTIE, MICHAEL; MARCHUT, ALEXANDER
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 068424/0985 →
Assignment of Assignor's Interest
Aug 28, 2024
From: YAMAGAMI, TAKAFUMI; OTSUKI, KAZUFUMI; YOTSUJI, KEISUKE
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 068422/0762 →
Assignment of Assignor's Interest
Feb 21, 2025
From: RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 070285/0762 →
Assignment of Assignor's Interest
Feb 21, 2025
From: RODMAN, DAVID; CONGLETON, JON
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 070285/0790 →
Assignment of Assignor's Interest
Jan 6, 2026
From: RODMAN, DAVID
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 073376/0325 →
Assignment of Assignor's Interest
Jan 7, 2026
From: RODMAN, DAVID; TORTORICI, MICHAEL
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 073393/0105 →